Evidence map›Paper›PMID 25894999›Full record

ArticleJournal of natural products2015

Inhibition of Human Prolyl Oligopeptidase Activity by the Cyclotide Psysol 2 Isolated from Psychotria solitudinum.

Roland Hellinger, Johannes Koehbach, Albert Puigpinós, Richard J Clark, Teresa Tarragó, Ernest Giralt, Christian W Gruber

Open access · hybridAbstract read
In one paragraph

Article in Journal of natural products, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Peptide hormones in plants.Molecular horticulture · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Cyclotides from BrazilianJournal of natural products · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Plant cystine-knot peptides: pharmacological perspectives.British journal of clinical pharmacology · 2017
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Roland Hellinger†Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria.
Johannes Koehbach†Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria.
Albert Puigpinós‡Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Richard J Clark⊥School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
Teresa Tarragó‡Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Ernest Giralt‡Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain.
Christian W Gruber†Center for Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria.
Institute for Research in Biomedicine · ESMedical University of Vienna · ATUniversity of Queensland · AU

Funding

Austrian Science Fund FWF P 24743
6 · The paper itself

Abstract

Cyclotides are head-to-tail cyclized peptides comprising a stabilizing cystine-knot motif. To date, they are well known for their diverse bioactivities such as anti-HIV and immunosuppressive properties. Yet little is known about specific molecular mechanisms, in particular the interaction of cyclotides with cellular protein targets. Native and synthetic cyclotide-like peptides from Momordica plants are potent and selective inhibitors of different serine-type proteinases such as trypsin, chymotrypsin, matriptase, and tryptase-beta. This study describes the bioactivity-guided isolation of a cyclotide from Psychotria solitudinum as an inhibitor of another serine-type protease, namely, the human prolyl oligopeptidase (POP). Analysis of the inhibitory potency of Psychotria extracts and subsequent fractionation by liquid chromatography yielded the isolated peptide psysol 2 (1), which exhibited an IC50 of 25 μM. In addition the prototypical cyclotide kalata B1 inhibited POP activity with an IC50 of 5.6 μM. The inhibitory activity appeared to be selective for POP, since neither psysol 2 nor kalata B1 were able to inhibit the proteolytic activity of trypsin or chymotrypsin. The enzyme POP is well known for its role in memory and learning processes, and it is currently being considered as a promising therapeutic target for the cognitive deficits associated with several psychiatric and neurodegenerative diseases, such as schizophrenia and Parkinson's disease. In the context of discovery and development of POP inhibitors with beneficial ADME properties, cyclotides may be suitable starting points considering their stability in biological fluids and possible oral bioavailability.

Indexed as

AlgorithmsAmino Acid SequenceChymotrypsinCyclotidesHumansMolecular StructureProlyl OligopeptidasesPsychotriaSerine EndopeptidasesSerine Proteinase InhibitorsSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStructure-Activity RelationshipTrypsinChymotrypsinCyclotideskalata B1PREPL protein, humanProlyl OligopeptidasesSerine EndopeptidasesSerine Proteinase InhibitorsTrypsin

Identifiers

PMID25894999
PMCPMC4444998
OpenAlexW2014438960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.